3 patents
Utility
Isoindoline compositions and methods for treating neurodegenerative disease
4 Jul 23
Isoindoline sigma-2 receptor antagonist compounds, pharmaceutical compositions comprising such compounds, and methods for inhibiting Abeta-associated synapse loss or synaptic dysfunction in neuronal cells, modulating an Abeta-associated membrane trafficking change in neuronal cells, and treating cognitive decline associated with Abeta pathology are provided.
Gilbert M. Rishton, Susan M. Catalano, Gary C. Look
Filed: 6 Feb 20
Utility
Compositions for treating neurodegenerative diseases
4 Jan 22
Gilbert M. Rishton, Gary C. Look, Susan M. Catalano
Filed: 15 May 18
Utility
Isoindoline compositions and methods for treating neurodegenerative disease
6 Apr 20
Isoindoline sigma-2 receptor antagonist compounds, pharmaceutical compositions comprising such compounds, and methods for inhibiting Abeta-associated synapse loss or synaptic dysfunction in neuronal cells, modulating an Abeta-associated membrane trafficking change in neuronal cells, and treating cognitive decline associated with Abeta pathology are provided.
Gilbert M. Rishton, Susan M. Catalano, Gary C. Look
Filed: 20 Dec 18
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first